This Type Of Vitamin E Could Predict Your Risk For Alzheimer's—And You're Probably Not Getting Enough Of It

Vitamin E is essential for normal neurological function, according to a 2013 Journal of Internal Medicine study, which found that low levels of some types of the vitamin could help predict your risk for Alzheimer's disease. Looking to take back control of your health? 

Some types? That's right: There are different types of vitamin E. In fact, there are 8 varieties or "isoforms" of E, and research suggests your brain needs all of them for optimal health and function.

Read more: This Type Of Vitamin E Could Predict Your Risk For Alzheimer's—And You're Probably Not Getting Enough Of It

Source: msn.com/en-us/health/nutrition

Watch Slides Video: 9 Ways To Control Your Risk Of Alzheimer's

Poor Protein Control Key to Alzheimer's Progression

Despite decades of research, the molecular mechanisms behind Alzheimer's disease are poorly understood. New research investigating the pattern of protein build-up in Alzheimer's brains may open the door to a deeper understanding.

Alzheimers is the most common form of dementia, with an estimated 5 million Americans living with the disease today.

It is a progressive condition, normally appearing around the age of 60.

Alzheimer's disease begins with mild memory loss and can end with the individual losing touch with the environment around them.

Although a great deal has been learned about the disease, there is no cure, and many questions remain unanswered.

Alzheimer's is characterized by a build-up of proteins in the brain, known as plaques and tangles.

Read more: Poor Protein Control Key to Alzheimer's Progression

Mapping the way in which protein is managed in the brain gives fresh insight into Alzheimer's.

Source: medicalnewstoday

Pre-Dementia Memory Loss Improved With Acupuncture

Acupuncture appears to be effective for the mild cognitive impairment that is a precursor for dementia, when used as an alternative or in combination with other treatment, a new study finds.

The review of available published evidence and presented in Acupuncture in Medicine shows promise for clinical effectiveness and safety of acupuncture use for the pre-dementia state. However, the authors caution that further, more rigorously designed studies are needed.

Min Deng, from the Department of Neurology at Zhongnan Hospital of Wuhan University in China, and Xu-Feng Wang, from the Department of General Surgery at Renmin Hospital of Wuhan University, conducted the study.

Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and the most severe decline of dementia.

Read more: Pre-Dementia Memory Loss Improved With Acupuncture

Acupuncture may assist with improving the subtle memory loss that precedes the development of
dementia.

Source: medicalnewstoday

Side Effects of Alzheimer's Gene Visible in Child Brain Development

Certain genes increase the risk of developing Alzheimer's disease. The side effects of the most common of these genes, apolipoprotein E, may be evident as early as in childhood, a study finds.

Genetic risks are just one of the factors that may increase or decrease a person's chances of developing Alzheimer's disease (AD), along with age and family history.

While the symptoms of the rarer early-onset AD - representing less than 5 percent of people with the disease - can appear from the age of 30, the symptoms of the more common type, late-onset AD, is apparent over the age of 65.

This study, published in the online issue of Neurology, finds that the effects of the AD gene apolipoprotein E (APOE) may possibly be seen before the age of 20.

Read more: Side Effects of Alzheimer's Gene Visible in Child Brain Development

Studying genes in childhood that increase the risk of developing Alzheimer's disease may possibly
help experts develop ways of delaying the disease.

Source: medicalnewstoday

Neurodegenerative disease damage reversed in fruit flies

Alzheimer's and Parkinson's symptoms have been reversed in fruit flies following treatment with a drug-like chemical, says research published in the Proceedings of the National Academy of Sciences.

The discovery, which centers around the protection of brain cells, could be a turning point in the fight against neurodegenerative disease, say the authors.

Neurodegenerative diseases occur when groups of nerve cells in the brain die, making it difficult for a person to move and to think.

According to Claire Bale, of Parkinson's UK, the symptoms of Parkinson's tend not to appear until 70 percent of nerve cells in the brain have already been lost.

Unfortunately, current treatments are only able to tackle the symptoms of the condition - they cannot slow or stop the degeneration of these cells.

Read more: Neurodegenerative disease damage reversed in fruit flies

Scientists are making progressing in techniques to protect nerve cells.

Source: medicalnewstoday

Unlocking the secret to healthy aging!

A new study may bring us closer to unlocking the secret to healthy aging, after uncovering an array of genetic variants among healthy, elderly individuals that may protect against Alzheimer's and heart disease.

The findings come from the ongoing "Wellderly" study, in which researchers have so far applied whole genome sequencing to the DNA of more than 1,400 healthy individuals from the US aged 80-105 years.

Launched in 2007, the study aims to pinpoint certain genetic variants that may contribute to lifelong health.

"This study is exciting because it is the first large one using genetic sequencing to focus on health," says Michael Snyder, PhD, chairman of the Department of Genetics at Stanford University in California, who was not involved with the research.

"Most of the world's scientists are studying disease, but what we really want to understand is what keeps us healthy. That is what the Wellderly study is all about."

Read more: Unlocking the secret to healthy aging!

Researchers have uncovered some of the secrets of healthy aging with their new gene study.

Source: medicalnewstoday

HIV Patients Now Living Long Enough to Develop Alzheimer's

Findings upend previous beliefs about brain changes related to the AIDS-causing virus

The first case of Alzheimer's disease diagnosed in a person with HIV highlights the fact that long-time HIV survivors are starting to reach ages where their risk for Alzheimer's increases, researchers report.

The 71-year-old man was diagnosed after a medical scan revealed amyloid protein clumps in his brain. Until now, it was believed that HIV-related inflammation in the brain might prevent the formation of such clumps and thereby protect these people from Alzheimer's.

"This patient may be a sentinel case that disputes what we thought we knew about dementia in HIV-positive individuals," said study author Dr. R. Scott Turner. He is head of the Memory Disorders Program at Georgetown University Medical Center in Washington, D.C.

The case also suggests that some older people with HIV and dementia may be misdiagnosed with HIV-associated brain disorders, but actually have Alzheimer's disease. It's also possible that some older people with HIV have both HIV-associated brain disorders and Alzheimer's, according to Turner.

"Chronic HIV infection and amyloid deposition with aging may represent a 'double-hit' to the brain that results in progressive dementia," he said in a university news release.

Read more: HIV Patients Now Living Long Enough to Develop Alzheimer's

Source: HealthDay/ScoutNews LLC